Different surface charge of colistin-susceptible and -resistant acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment

Search results

• Finished

  Optimizing dosing of colistin for infections resistant to all other antibiotics.

  Nation, R. (Primary Chief Investigator (PCI)) & Li, J. (Chief Investigator (CI))

  NIH - National Institutes of Health (United States of America)

  15/09/08 → 31/08/12

  Project: Research

• Targeting MD hetero-resistant Gram-negatives: PK/PD for rational combinations.

  Nation, R. (Primary Chief Investigator (PCI)), Li, J. (Chief Investigator (CI)), Forrest, A. (Partner Investigator (PI)), Paterson, D. L. (Partner Investigator (PI)) & Tsuji, B. T. (Partner Investigator (PI))

  NIH - National Institutes of Health (United States of America)

  15/07/08 → 30/06/12

  Project: Research